Boorjian SA - Search Results

1

Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.

Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML. Siddiqui SA, et al. Among authors: boorjian sa. J Urol. 2008 May;179(5):1830-7; discussion 1837. doi: 10.1016/j.juro.2008.01.022. Epub 2008 Mar 18. J Urol. 2008. PMID: 18353378

2

Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening.

Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, Davis R, Hellstrom W. Mulhall JP, et al. Among authors: boorjian sa. J Urol. 2004 Jun;171(6 Pt 1):2350-3. doi: 10.1097/01.ju.0000127744.18878.f1. J Urol. 2004. PMID: 15126819

3

Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.

Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS. Boorjian S, et al. Urology. 2004 Aug;64(2):383-8. doi: 10.1016/j.urology.2004.03.025. Urology. 2004. PMID: 15302512

4

Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?

Boorjian SA, Bianco FJ Jr, Scardino PT, Eastham JA. Boorjian SA, et al. BJU Int. 2005 Oct;96(6):773-6. doi: 10.1111/j.1464-410X.2005.05763.x. BJU Int. 2005. PMID: 16153197

5

Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?

Vickers AJ, Bianco FJ Jr, Boorjian S, Scardino PT, Eastham JA. Vickers AJ, et al. Cancer. 2006 Feb 1;106(3):576-80. doi: 10.1002/cncr.21643. Cancer. 2006. PMID: 16353213 Free PMC article.

6

Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor.

Boorjian S, Cowan JE, Konety BR, DuChane J, Tewari A, Carroll PR, Kane CJ; Cancer of the Prostate Strategic Urologic Research Endeavor Investigators. Boorjian S, et al. J Urol. 2007 Mar;177(3):883-7; discussion 887-8. doi: 10.1016/j.juro.2006.10.071. J Urol. 2007. PMID: 17296367

7

Renal cell carcinoma: vena caval involvement.

Boorjian SA, Sengupta S, Blute ML. Boorjian SA, et al. BJU Int. 2007 May;99(5 Pt B):1239-44. doi: 10.1111/j.1464-410X.2007.06826.x. BJU Int. 2007. PMID: 17441917 Review. No abstract available.

8

Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy.

Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ. Blute ML, et al. Among authors: boorjian sa. J Urol. 2007 Aug;178(2):440-5; discussion 444. doi: 10.1016/j.juro.2007.03.121. Epub 2007 Jun 11. J Urol. 2007. PMID: 17561151

9

Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.

Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. Boorjian SA, et al. J Urol. 2007 Sep;178(3 Pt 1):864-70; discussion 870-1. doi: 10.1016/j.juro.2007.05.048. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631342

10

Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers.

Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Frank I, Blute ML. Boorjian SA, et al. BJU Int. 2008 Feb;101(3):299-304. doi: 10.1111/j.1464-410X.2007.07269.x. Epub 2007 Oct 8. BJU Int. 2008. PMID: 17922854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters